Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 680 JPY -4.63% Market Closed
Market Cap: 270.6B JPY

Intrinsic Value

The intrinsic value of one Sumitomo Pharma Co Ltd stock under the Base Case scenario is 806.36 JPY. Compared to the current market price of 680 JPY, Sumitomo Pharma Co Ltd is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
806.36 JPY
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sumitomo Pharma Co Ltd

Sumitomo Pharma Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Sumitomo Pharma Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Sumitomo Pharma Co Ltd
TSE:4506
JP
Pharmaceuticals
Market Cap
270.2B JPY
IPO
May 16, 1949
JP
Pharmaceuticals
Market Cap
270.2B JPY
IPO
May 16, 1949
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Sumitomo Pharma Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sumitomo Pharma Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sumitomo Pharma Co Ltd

Current Assets 333.7B
Cash & Short-Term Investments 102B
Receivables 97.3B
Other Current Assets 134.4B
Non-Current Assets 518.4B
Long-Term Investments 38.2B
PP&E 52.6B
Intangibles 403.3B
Other Non-Current Assets 24.4B
Efficiency

Free Cash Flow Analysis
Sumitomo Pharma Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sumitomo Pharma Co Ltd

Revenue
372.7B JPY
Cost of Revenue
-147.2B JPY
Gross Profit
225.6B JPY
Operating Expenses
-449.4B JPY
Operating Income
-223.9B JPY
Other Expenses
47.8B JPY
Net Income
-176B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sumitomo Pharma Co Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Declining ROE
20/100
Profitability
Score

Sumitomo Pharma Co Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sumitomo Pharma Co Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
29/100
Solvency
Score

Sumitomo Pharma Co Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sumitomo Pharma Co Ltd

Wall Street analysts forecast Sumitomo Pharma Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sumitomo Pharma Co Ltd is 644.06 JPY with a low forecast of 424.2 JPY and a high forecast of 945 JPY.

Lowest
Price Target
424.2 JPY
38% Downside
Average
Price Target
644.06 JPY
5% Downside
Highest
Price Target
945 JPY
39% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sumitomo Pharma Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Sumitomo Pharma Co Ltd stock?

The intrinsic value of one Sumitomo Pharma Co Ltd stock under the Base Case scenario is 806.36 JPY.

Is Sumitomo Pharma Co Ltd stock undervalued or overvalued?

Compared to the current market price of 680 JPY, Sumitomo Pharma Co Ltd is Undervalued by 16%.

Back to Top